Fig. 7: The schematic model of the hypothesized mechanism by which PKC-δ ablation selectively in B cells affects bone remodeling.

PKC-δ deficiency in B cells favors bone mass loss, which is owing to the overexpression and secretion of RANKL in these B cells of hyperproliferation and the subsequent osteoclast–osteoblast uncoupling.